Source link : https://www.newshealth.biz/health-news/eye-toxicities-are-a-growing-concern-with-certain-adcs/
Despite being a targeted therapy, antibody-drug conjugates (ADCs) can cause significant off-target toxicity to the eyes of patients being treated for advanced multiple myeloma or cervical cancer, yet the risks remain relatively unknown, according to oncologists and ophthalmologists. Such experts called for greater collaboration between oncologists and ophthalmologists, in interviews with Medscape Medical News. ADCs […]
Author : News Health
Publish date : 2024-12-11 13:08:20
Copyright for syndicated content belongs to the linked Source.